Xconomist of the Week and a Prize Re-launch! Posted on: May 17, 2012
Dr. Tom Maniatis, a member of Prize4Life's Scientific Advisory Board, speaks to Arlene Weintraub of Xconomy as "Xconomist of the Week" about how he became involved with Prize4Life through ALS patient and CEO, Avi Kremer. In this article, Prize4Life also announces the re-launch of our $1M ALS Treatment
Prize4Life, which is a revival of our inaugural award's goal; the promise of $1 million for a therapy that demonstrates 25 percent survival in ALS mice. In the previous round, no one was able to achieve that, but there are so many
advances now in the genetic identification of potential new targets. I think it's going to open up a new phase that should be exciting and interesting," Maniatis says.